|

Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis

RECRUITINGN/ASponsored by University of Alabama at Birmingham
Actively Recruiting
PhaseN/A
SponsorUniversity of Alabama at Birmingham
Started2026-08-01
Est. completion2027-09-01
Eligibility
Age18 Years – 64 Years
Healthy vol.Accepted
Locations1 site

Summary

The goal of this clinical trial is to learn if the time an individual eats each day impacts neurological health in people with multiple sclerosis. The main questions the investigators are asking are: 1. Does meal timing affect biomarkers of neuronal health (neurofilament light chain \[NfL\] and BDNF) and inflammation (IL-6, IL-17, TNF-ɑ) in adults with MS. 2. Does meal timing affect expression of circadian clock genes and genes associated with autophagy in adults with MS. Participants will be instructed to start and stop eating at specific times each day based on their group assignment and their personal schedule. They will respond to prompts sent to them on their smartphone to record the times they start and stop eating each day. As a secondary goal, the study will also explore the feasibility of including translocator protein (TSPO)-PET imaging of neuroinflammation in future clinical trials of TRE in people with MS. To accomplish this, imaging will be completed in a subset of 8 participants at the beginning and end of the study.

Eligibility

Age: 18 Years – 64 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosed with relapsing remitting or secondary progressive multiple sclerosis (RRMS or SPMS)
* If on disease modifying therapy (DMTs), stable for 6 months
* If not on DMTs, no DMT usage within previous 6 months
* BMI 18.5-50 kg/m2
* Access to a smartphone
* Responsible for personal eating schedule or able to have input into schedule

Exclusion Criteria:

* Relapse within previous 30 days
* Actively engaged in a weight loss program or unwilling to follow assigned eating schedule
* Current use of GLP-1 or use within previous 3 months
* Regularly fasts \> 12 hours/day
* Employed in night shift or rotating shift work
* Unable to walk 25 feet with or without assistive device (EDSS \> 6.5).
* Current use of insulin or sulfonylurea agents
* Pregnant or breastfeeding
* Currently enrolled in another trial that would confound results (e.g., exercise studies or other diet studies)

Conditions1

Multiple Sclerosis

Locations1 site

University of Alabama at Birmingham
Birmingham, Alabama, 35294

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.